NasdaqCM - Nasdaq Real Time Price USD

Monopar Therapeutics Inc. (MNPR)

39.42
-2.95
(-6.96%)
At close: May 9 at 4:00:01 PM EDT
39.42
0.00
(0.00%)
After hours: May 9 at 4:05:12 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
0
0
Operating Expense
16,161.72
16,161.72
8,831.24
10,536.88
9,127.25
Operating Income
-16,161.72
-16,161.72
-8,831.24
-10,536.88
-9,127.25
Net Non Operating Interest Income Expense
404.02
404.02
429.04
21.24
24.02
Other Income Expense
171.28
171.28
--
--
--
Pretax Income
-15,586.42
-15,586.42
-8,402.20
-10,515.64
-9,103.22
Net Income Common Stockholders
-15,586.42
-15,586.42
-8,402.20
-10,515.64
-9,103.22
Diluted NI Available to Com Stockholders
-15,586.42
-15,586.42
-8,402.20
-10,515.64
-9,103.22
Basic EPS
-1.98
-4.11
-3.04
-4.15
-3.65
Diluted EPS
-1.98
-4.11
-3.04
-4.15
-3.65
Basic Average Shares
3,296.51
3,790.20
2,764.79
2,543.63
2,494.24
Diluted Average Shares
3,296.51
3,790.20
2,764.79
2,543.63
2,494.24
Total Operating Income as Reported
-16,161.72
-16,161.72
-8,831.24
-10,536.88
-9,127.25
Total Expenses
16,161.72
16,161.72
8,831.24
10,536.88
9,127.25
Net Income from Continuing & Discontinued Operation
-15,586.42
-15,586.42
-8,402.20
-10,515.64
-9,103.22
Normalized Income
-15,586.42
-15,586.42
-8,402.20
-10,515.64
-9,103.22
Interest Income
404.02
404.02
429.04
21.24
24.02
Net Interest Income
404.02
404.02
429.04
21.24
24.02
EBIT
-16,161.72
-16,161.72
-8,831.24
-10,536.88
-9,127.25
EBITDA
-16,161.72
-16,161.72
-8,831.24
-10,536.88
-9,127.25
Net Income from Continuing Operation Net Minority Interest
-15,586.42
-15,586.42
-8,402.20
-10,515.64
-9,103.22
Total Unusual Items Excluding Goodwill
--
--
--
--
0
Total Unusual Items
--
--
--
--
0
Normalized EBITDA
-16,161.72
-16,161.72
-8,831.24
-10,536.88
-9,127.25
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 12/19/2019

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

DRUG Bright Minds Biosciences Inc.
32.49
+1.34%
 
PRQR ProQR Therapeutics N.V.
1.6100
+3.87%
 
STOK Stoke Therapeutics, Inc.
9.36
+3.43%
 
DBVT DBV Technologies S.A.
9.83
-0.10%
 
QNRX Quoin Pharmaceuticals, Ltd.
6.19
-3.43%
 
XFOR X4 Pharmaceuticals, Inc.
3.3700
+2.43%
 
LPTX Leap Therapeutics, Inc.
0.3350
-7.23%
 
WVE Wave Life Sciences Ltd.
6.59
+0.69%
 
ACTU Actuate Therapeutics, Inc. Common stock
10.35
+4.55%
 
RYTM Rhythm Pharmaceuticals, Inc.
57.38
-5.50%